Oskar Hansson
451 – 500 of 544
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia
(
- Contribution to journal › Article
-
Mark
Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort.
(
- Contribution to journal › Article
-
Mark
Prediction of instability in people with Parkinson’s disease - clinical balance and gait tests.
2013) International Congress of Parkinson's Disease and Movement Disorders, 2013 In [Publication information missing] 28(S1). p.163-163(
- Contribution to journal › Published meeting abstract
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
2013) Endokrindagarna, 2013(
- Contribution to conference › Poster
-
Mark
Future falls and/or near falls in people with Parkinson’s disease: Sensitivity and specificity of two retropulsion tests
2013) International Congress of Parkinson's Disease and Movement Disorders, 2013 In Movement Disorders 28(S1). p.163-163(
- Contribution to journal › Published meeting abstract
-
Mark
Walking difficulties is the strongest contributing factor to fear of falling among people with mild Parkinson's disease.
(
- Contribution to journal › Published meeting abstract
-
Mark
ROI-based analysis of diffusional kurtosis estimates for identification of MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
2013) ISMRM, 2013(
- Contribution to conference › Poster
- 2012
-
Mark
Age and diagnostic performance of Alzheimer disease CSF biomarkers
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
No diagnostic value of plasma clusterin in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer's Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study.
(
- Contribution to journal › Article
-
Mark
Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Evaluation of Plasma A beta as Predictor of Alzheimer's Disease in Older Individuals Without Dementia: A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study
(
- Contribution to journal › Article
-
Mark
Amyloid-beta Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.
(
- Contribution to journal › Article
-
Mark
Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.
(
- Contribution to journal › Article
-
Mark
Diffusion tensor tractography of the posterior cingulate gyrus and corpus callosum does not identify MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2011
-
Mark
Cerebrospinal Fluid Microglial Markers in Alzheimer's Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
(
- Contribution to journal › Article
-
Mark
Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Differences in Survival between Patients with Dementia with Lewy Bodies and Patients with Alzheimer's Disease - Measured from a Fixed Cognitive Level.
(
- Contribution to journal › Article
-
Mark
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women.
(
- Contribution to journal › Article
-
Mark
Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.
(
- Contribution to journal › Article
-
Mark
Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
(
- Contribution to journal › Article
- 2010
-
Mark
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A beta 40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
(
- Contribution to journal › Article
-
Mark
Low Incidence of Post-Lumbar Puncture Headache in 1,089 Consecutive Memory Clinic Patients
(
- Contribution to journal › Article
-
Mark
Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment.
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cystatin C Levels are Positively Correlated with both A beta(42) and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
(
- Contribution to journal › Article
-
Mark
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls
(
- Contribution to journal › Article
-
Mark
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta 40 and A beta 42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment Response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
(
- Contribution to journal › Article
-
Mark
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
(
- Contribution to journal › Article
-
Mark
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
(
- Contribution to journal › Article
-
Mark
An enzyme activity as a potential biomarker for Alzheimer's disease.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.497-498(
- Contribution to journal › Published meeting abstract
-
Mark
Convergence of chromogranin and amyloid metabolism in the brain.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.511-511(
- Contribution to journal › Published meeting abstract
-
Mark
A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
(
- Contribution to journal › Article